Dermatology and Allergic Disease Grants

The AKC Canine Health Foundation is committed to canine health by seeking critical research to diagnose, prevent and/or treat dermatological and allergic disease in dogs.  The Foundation supports novel and multi-disciplinary approaches to addressing the health needs of all dogs.  

Active Grants:

 03215-A Investigation of the Role of Staphylococcus pseudintermedius Phenol-soluble Modulins in Canine Pyoderma
 03162 Fecal Microbiota Transplantation for Treatment of Canine Atopic Dermatitis
 03166-A Evaluation of the Effects of Diluted Sodium Hypochlorite on Skin Microbiome in Dogs with Superficial Pyoderma and Atopic Dermatitis: a Single Blinded, Randomized, Controlled Clinical Trial
 02837 Duration of Antibiotic Therapy for Canine Superficial Pyoderma: Is the One-Week Post Resolution of Clinical Signs a Valid Rule-of-Thumb?

Previously Awarded Grants:

Items 1 - 25 of 41  12Next
 02694 Investigation on the Molecular Crosstalk between Canine Atopic Skin and Microbes: Unraveling Potential Pathomechanisms for Chronic Recurrent Skin Infections
 02921-MOU Transcriptome Profiling of Canine Familial Dermatomyositis Skin Lesions and Treatment with a JAK Inhibitor to Identify Novel Pathways Involved in Pathogenesis
 02673-MOU Searching for the Cause for Alopecia X by Whole Genome Sequencing
 02829 Investigating the Potential of Phage Therapy to Tackle Staphylococcus pseudintermedius Infections in Dogs
 02597 Molecular Epidemiology of Methicillin-resistant Staphylococcus pseudintermedius in the United States
 02825-A Effect(s) of Atopic Dermatitis-associated Cytokines on Staphylococcus pseudintermedius
 02651 Discovery of Novel Biomarkers of Canine Atopic Dermatitis through Lipid Profiling
 02653-A Evaluation of the Serum and Cutaneous Levels of Chemokines in Atopic Dogs
 02241 The City Dog Study: Dermatologic and Respiratory Disease among Inner-City Dogs Living in the Homes of Children with Asthma
 02472-A Effect of Lokivetmab on Tissue Biomarkers of Canine Atopic Dermatitis using RNA Sequencing
 02176-A Intralymphatic Immunotherapy for the Treatment of Canine Atopic Dermatitis
 02182-A Is Defective Secretion of Antimicrobial Peptides Associated with Reduced Microbicidal Effects in Atopic Keratinocytes?
 02261-MOU Improvement of Risk Assessments for Dermatomyositis Testing
 02116-A Establishing Best Practices in the Treatment of Atopic Dermatitis to Prevent Antimicrobial Resistance
 02111-A Evaluating the Contribution of Fungal Infection to the Pathogenesis of Atopic Dermatitis: Putting Evidence under the Use of Antifungal Medication
 01746-A Discovery of the Genetic Cause of Lethal Acrodermatitis
 01586 Identifying the Genetic Cause of Sebaceous Adenitis
 01620 Targeting Immune Cells as a Novel Treatment for Canine Atopic Dermatitis
 01591 Identification of the Genes That Confer Risk for Atopic Dermatitis
 01421 Genomic Resources for the Control of Canine Pyoderma
 01415 Development of Anti-IgE Peptide for Treatment of Canine Allergy
 01663-A Placebo-controlled trial of T-cell receptor (TCR) peptide treatment in dogs with non-responsive atopic dermatitis
 01547-A Genetic Analysis of Alopecia X in Pomeranians
 01346-A Genetic Basis of Sebaceous Adenitis in Dogs
 01240-A Development of a Diagnostic Method for Canine Atopic Dermatitis

The AKC Canine Health Foundation funds research in 23 different Research Program Areas for the health of all dogs. These program areas enable the Foundation to create depth in our research portfolio and help us to be responsive to the health concerns of our constituents.

Donate to Support this Research Program Area

Help Future Generations of Dogs

Participate in canine health research by providing samples or by enrolling in a clinical trial. Samples are needed from healthy dogs and dogs affected by specific diseases.

Learn How to Help

Get Canine Health News:
Please leave this field empty
American Kennel Club Canine Health Foundation, Inc

8051 Arco Corporate Dr.
Suite 300
Raleigh, NC 27617

Tax ID# 13-3813813


© 2021 AKC Canine Health Foundation | Privacy Policy | Site Map

Site by Blackbaud, Inc.